Danaher Corp
F:DAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Danaher Corp
F:DAP
|
US |
Intrinsic Value
The intrinsic value of
Danaher Corp (DAP) under the Base Case is 210.27 EUR per share.
Compared with the current market price of 207 EUR, the stock appears
Undervalued by 2% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Danaher Does
Danaher is a tools-and-equipment company that sells products used to test, measure, and make things in life sciences, diagnostics, and water quality. Its businesses include lab instruments, medical testing systems, bioprocessing equipment for drug makers, and water analysis and treatment products. Customers include pharmaceutical and biotech companies, hospitals and clinical labs, research institutions, and industrial and municipal water users.
- Headquarters
- United States of America US
- Employees
- 58 000
- IPO date
- Dec 10, 1969
Danaher has a wide economic moat
Replacing Danaher’s tools can require customers to repeat safety and performance checks, retrain staff and risk interrupting drug production or laboratory testing. Patented technology and regulatory clearances also make it harder for rivals to copy its diagnostic systems and tests.
Read the full moat analysis
Revenue & Expenses Breakdown
Danaher Corp
Earnings Waterfall
Danaher Corp
The intrinsic value for
Danaher Corp (DAP) under the Base Case is 210.27 EUR.
Compared with the current market price of 207 EUR, the stock appears Undervalued by 2% .